Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,428 | 3,813 | 4,733 | 5,875 | 7,092 |
| Receivables | N/A | N/A | 19 | N/A | N/A |
| Other current assets | 114 | 86 | 26 | 94 | 199 |
| TOTAL | $11,542 | $3,898 | $4,779 | $5,969 | $7,291 |
| Non-Current Assets | |||||
| PPE Net | 980 | 816 | 814 | 852 | 900 |
| TOTAL | $980 | $816 | $814 | $852 | $900 |
| Total Assets | $12,522 | $4,714 | $5,593 | $6,820 | $8,191 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18 | 36 | 53 | 70 | 69 |
| Accounts payable and accrued liabilities | 668 | 374 | 485 | 507 | 504 |
| Accrued Expenses | 375 | 336 | 245 | 333 | 328 |
| TOTAL | $1,061 | $745 | $783 | $910 | $901 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1,175 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,175 |
| Total Liabilities | $1,061 | $745 | $783 | $910 | $2,076 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70 | 69 | 56 | 55 | 47 |
| Common Shares | 231 | 185 | 185 | 184 | 156 |
| Retained earnings | -96,020 | -94,712 | -93,778 | -92,487 | -90,666 |
| TOTAL | $11,462 | $3,969 | $4,810 | $5,910 | $6,115 |
| Total Liabilities And Equity | $12,522 | $4,714 | $5,593 | $6,820 | $8,191 |